View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
A study designed to compare magnesium sulfate and nifedipine as treatments for preterm labor involved 192 women who were in active preterm labor at 24 to nearly 34 weeks gestation. Of those, 92 women were randomly chosen to receive I.V. magnesium sulfate and 100 women received sublingual and oral nifedipine. Treatment continued until at least 12 hours of uterine quiescence was achieved in 48 hours. (Uterine quiescence was defined as six or fewer contractions per hour.)
Comparing responses with the two drugs, researchers found no differences in delivery within 48 hours, gestational age at delivery, birth before 37 and 32 weeks, and episodes of recurrent preterm labor. But women who'd received magnesium sulfate were significantly more likely to experience mild and severe adverse reactions, such as lethargy, nausea and vomiting, dizziness, shortness of breath, pulmonary edema, hypotension, and chest pain.
Birth weights and neonatal complications were similar between the two groups, but infants whose mothers had received magnesium sulfate stayed in the neonatal ICU more than twice as long (8.8 days versus 4.2 days).
Lyell DJ, et al., Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor, Obstetrics & Gynecology, July 2007.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top